## Clinical Context This patient presents with a clinically suspicious breast mass (hard, irregular, with skin changes) and imaging findings suggestive of malignancy. The next critical step is histological confirmation before any definitive treatment. ## Why Core Needle Biopsy is the Correct Answer **Key Point:** Histological diagnosis is mandatory before staging or treatment in suspected breast cancer. Core needle biopsy (CNB) is the gold standard for tissue diagnosis in breast lesions. **High-Yield:** The diagnostic algorithm for breast lesions follows this sequence: 1. Clinical examination and imaging (already done) 2. **Tissue diagnosis** (CNB or excision biopsy) 3. Staging investigations 4. Treatment planning **Clinical Pearl:** Core needle biopsy offers: - High sensitivity (95–98%) and specificity (>99%) - Allows assessment of histological type and grade - Permits hormone receptor and HER2 testing (essential for treatment decisions) - Can be performed as outpatient procedure - Lower morbidity than excision biopsy ## Management Sequence ```mermaid flowchart TD A[Suspicious breast mass on clinical exam + imaging]:::outcome --> B[Tissue diagnosis required?]:::decision B -->|Yes| C[Core needle biopsy]:::action C --> D[Histology + IHC obtained]:::outcome D --> E[Malignancy confirmed?]:::decision E -->|Yes| F[Staging investigations]:::action E -->|No| G[Benign lesion - follow-up]:::outcome F --> H[Treatment planning]:::action ``` ## Why Other Options Are Premature | Step | Rationale for Deferral | |------|------------------------| | **Staging investigations** | Cannot stage without confirmed diagnosis; wastes resources and delays treatment | | **Immediate surgery** | Contraindicated without histological confirmation; may be inappropriate if benign | | **Hormonal therapy** | Premature; requires ER/PR status from biopsy; no diagnosis yet | [cite:Robbins 10e Ch 24]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.